Close menu




September 8th, 2021 | 12:28 CEST

PuriflOH, Bayer, Philips - Innovations as yield drivers

  • Investments
Photo credits: pixabay.com

Innovations enrich our everyday lives in many ways. The following companies have developed innovative solutions for health and climate in the broadest sense that help remedy important problems. The focus here is on water, a scarce resource, and air purification, which in times of Corona plays an increasingly important role. Which Company has the best opportunities?

time to read: 3 minutes | Author: Carsten Mainitz
ISIN: PURIFLOH LTD | AU0000010548 , BAYER AG NA O.N. | DE000BAY0017 , KONINKL. PHILIPS EO -_20 | NL0000009538

Table of contents:


    Jared Scharf, CEO, Desert Gold Ventures Inc.
    "[...] We have built one of the largest land packages of any non-producer in the belt at over 440 sq.km and have made more than 25 gold discoveries on the property to date with 5 of these discoveries totaling about 1.1 million ounces of gold resources. [...]" Jared Scharf, CEO, Desert Gold Ventures Inc.

    Full interview

     

    PURIFLOH LIMITED - Innovator from Australia with worldwide patents

    Founded in Australia with a US office in Detroit, PuriflOH has developed innovative and globally patented technology for cleaning air, water and surfaces in residential, commercial and industrial settings. According to the Company, PuriflOH has developed the first and only single solution to remove biological and chemical contaminants from the air through a two-step process.

    IP licensing and partnership opportunities with air purification equipment manufacturers for residential, commercial and industrial applications are currently being explored. PuriflOH solutions are easily expandable and, therefore, scalable. In the past, the Company undertook significant research activities to develop the Free Radical Generator (FRG) technology. Now, the Company is leveraging the expertise of Somnio Group for further development.

    Most recently, the Australians announced that commercialization activities would resume in Australia with two new products. These are the Air Conditioning Environmental Remediation Treatment (ACERT) and the Whole of Room Air Purifier (WRAP). In addition, PuriflOH built relationships with Aspen Medical, a healthcare solutions company, and Osmoflo, a water treatment company. Both partners play an important role in the future commercialization of the products.

    The Company is still in the red, but this is characteristic of the relatively early stage. However, the loss was significantly reduced in the fiscal year. In addition, the Company secured an AUD 1 million financing facility from its major shareholder Dilato. Currently, PuriflOH is valued at AUD 53 million. As the products are commercialized, operating income will quickly materialize. Technology-savvy investors should put the shares on their watchlist.

    BAYER AG - Turnaround in sight?

    Climate change is again causing problems for agriculture this year. According to the recently published harvest report by the German Federal Ministry of Agriculture and statements by the farmers' association, heavy rain and hail will lead to a 2.7% decline in the grain harvest this year. Compared to the years 2015 to 2020, this is even a decrease of 4.8%. While too much water has caused problems in this country, water scarcity is a major problem globally. 70% of the world's water is consumed by agriculture. By the end of the decade, demand will already exceed supply. Water is thus becoming a crucial bottleneck factor.

    Even if Bayer is more present in the media through its pharmaceuticals business and its cooperation with the Corona vaccine manufacturer CureVac, whose vaccine has not yet reached the marketing stage due to a lack of vaccine protection, Bayer's strong second pillar is agricultural chemistry. Here, the DAX-listed Company is focusing on targeted research activities to enable water-efficient agriculture. It also develops and markets products and technologies for improved wastewater treatment. Disappointing half-year figures and the lawsuits pending for some time in the USA in connection with carcinogenic fertilizers from the acquired competitor Monsanto led to a significant underperformance of around 10% against the DAX this year. 2021 will undoubtedly be a challenging year for the Group, but analysts expect things to pick up again significantly in 2022. The 2022 P/E ratio is 10, and the stock is currently interesting for anti-cyclical investors.

    KONINKLIJKE PHILIPS NV - Established player with industry-standard valuation

    Koninklijke Philips NV is a leading healthcare technology company with a wide range of products from healthy living and prevention to diagnosis, treatment and home care. The Group uses advanced technologies and sound clinical and consumer insights to provide integrated solutions. The Dutch-based Company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, and consumer health and home care. In Corona times, the air purifier sector has taken on greater importance. The Group is currently valued at around EUR 37 billion, 2 times projected 2022 sales and a 2022 P/E of 24.


    The featured stocks focus on climate, health and water as a resource. In doing so, all companies focus on different areas. Bayer is one of the leading players in agricultural chemicals. After a year of losses, next year should see a return to gratifying profits - this makes the shares interesting. Anyone who wants to invest in a young technology company that offers a range of innovative solutions should take a closer look at the PuriflOH share.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by André Will-Laudien on May 13th, 2025 | 07:20 CEST

    Defense out - Time to buy commodities! Hensoldt, Globex Mining, Barrick, Mutares, and Steyr

    • Mining
    • Gold
    • Defense
    • Investments

    That is how quickly market darlings can fall out of favor. Just last week, Rheinmetall & Co. were hitting record highs, but as of Monday, the euphoria came to a sudden halt. Trump agreed with China on lower tariffs, and Volodymyr Zelenskyy will travel to Turkey on Thursday to sit down with Russia's aggressor, Vladimir Putin. At the moment, this is still hard to believe. For the capital markets, however, this means a shift: out of defense and into high-tech and automotive stocks, the biggest winners of recent hours. The whole thing could be seen as a healthy rotation, as the major indices are at record levels, while tech and automotive stocks have corrected significantly in recent weeks. Once again, the cards are being reshuffled. For Globex Mining, the setback is suitable for medium-term follow-up purchases.

    Read

    Commented by Armin Schulz on May 13th, 2025 | 07:00 CEST

    When returns meet security: Why Almonty Industries is suddenly everyone's darling!

    • Mining
    • Tungsten
    • Defense
    • Investments

    In 2025, the world looks at a map full of conflicts: tensions are escalating in Ukraine, the Middle East, and along new geopolitical fault lines in Asia and Africa. Hopes for peace are giving way to a reality of rearmament and militarization. This dynamic is fueling the defense industry. But its boom depends on an inconspicuous metal: tungsten. With its unique heat resistance and density, it is irreplaceable for armor-piercing ammunition, missiles, and high-performance alloys. While China dominates the global market, a Canadian company is stepping into the spotlight: Almonty Industries. With the revival of the legendary Sangdong mine in South Korea and strategic partnerships, Almonty could become a key player for the West.

    Read

    Commented by André Will-Laudien on May 8th, 2025 | 07:10 CEST

    Almonty Industries – The next 100% opportunity with strategic metals

    • Mining
    • Tungsten
    • Investments

    Things continue to go well for Almonty Industries (TSX: AII; WKN: A1JSSD; ISIN: CA0203981034; EUR 1.59). The stock is already one of the best commodity stocks for 2025. The market is gradually realizing that this story could be worth billions. The trade dispute between the US and many nations is proving to be a death blow for Western industries, especially those in China. In response to announced trade tariffs of over 100%, the leadership in Beijing has imposed export restrictions on strategic metals. Tungsten is one of the most critical metals, essential for high-tech and defense applications. Deposits and producers are few and far between, with a good 70% of supply coming from China. Almonty Industries is set to start production in South Korea in 2025, and US producers are already securing valuable tungsten. A jump in valuation is on the cards!

    Read